Key figures
Highlights
2021 Revenue
| 2,146.7 Million euros |
+17.9% organic growth in 2021 |
Revenue by Region in 2021
| 17% Asia-Pacific |
36% Americas |
47% EMEA |
| In millions of euros | 2021 revenue | Contribution | Organic growth 2021/2020 | Organic growth 2021/2019 |
|---|---|---|---|---|
| Europe, Middle East and Africa | 1,014.5 | 47% | 17% | 19.5% |
| Americas | 773.1 | 36% | 20% | 6% |
| Asia-Pacific | 359.2 | 17% | 14.5% | -2% |
| Full-Year Revenues | 2,146.7 | 100% | 17.9% | 10.4% |
Revenue by Audience in 2021
| 17% Doctors & Patients |
18% Citizens |
21% Clients & Employees |
44% Consumers |
| In million of euros | 2021 revenue | Contribution | Organic growth 2021/2020 | Organic growth 2021/2019 |
|---|---|---|---|---|
| Consumers1 | 945.8 | 44% | 25% | 9% |
| Clients and employees2 | 452.2 | 21% | 14% | -9% |
| Citizens3 | 376.4 | 18% | 6% | 36.5% |
| Doctors and patients4 | 372.3 | 17% | 18% | 23.5% |
| Full-Year Revenues | 2,146.7 | 100% | 17,9% | 10.4% |
Breakdown of Service Lines by audience segment:
1- Brand Health Tracking, Creative Excellence, Innovation, Ipsos UU, Ipsos MMA, Market Strategy & Understanding, Observer (excl. public sector), Social Intelligence Analytics
2- Automotive & Mobility Development, Audience Measurement, Customer Experience, Channel Performance (including Retail Performance and Mystery Shopping), Media development
3- Public Affairs, Corporate Reputation
4- Pharma (quantitative and qualitative)
Summary consolidated financial statement
| In million of euros | 2021 | 2020 |
|---|---|---|
| Revenue | 2,146.7 | 1,873.4 |
| Gross profit | 1,389.3 | 1,180.5 |
| Operating margin | 277.4 | 189,9 |
| Adjusted net profit*, attributable to the Group | 209.2 | 129,6 |
| Workforce as of 31 December | 18,257 | 16,644 |
*Adjusted net profit is calculated before (i) non-cash items related to IFRS 2 (share-based compensation), (ii) amortisation of acquisition-related intangible assets (client relations), (iii) the impact net of tax of other noncurrent income, (iv) expense and the non-monetary impact of changes in puts in other financial income and expenses, (v) deferred tax liabilities related to goodwill for which amortisation is deductible in some countries.
Financial statement
| In million of euros | 2021 | 2020 |
|---|---|---|
| Total shareholders' equity | 1,342 | 1,122 |
| Financial debt | 181 | 347 |
| Free cash flow | 346 | 369 |
| Net debt / EBITDA | x 0,5 | x 1.6 |
| Net gearing | 13.4% | 30.9% |
Share capital and voting rights as at 31 December 2020
| Number of shares | % | Number of voting rights | % | |
|---|---|---|---|---|
| DT & Partners | 4,406,988 | 9.92 | 8,813,976 | 17.82 |
| Didier Truchot | 277,351 | 0.62 | 549,901 | 1.11 |
| Public | 38,233,559 | 86.04 | 38,363,509 | 77.59 |
| Employees | 970,635 | 2.19 | 1,718,590 | 3.48 |
| Including FCPE and Group savings plan | 17,812 | 0.04 | 35,624 | 0.072 |
| Treasury shares | 547,702 | 1.23 | 0 | 0.00% |
| Of which liquidity agreement | 15,581 | 0.04 | 0 | 0.00% |
| Total | 44,436,235 | 100 | 49,445,976 | 100 |